[{"address1": "2450 Holcombe Blvd.", "address2": "Suite X", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "713 913 5608", "website": "https://www.salariuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Salarius Pharmaceuticals, Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. Salarius Pharmaceuticals, Inc. is based in Houston, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mark J. Rosenblum CPA", "age": 72, "title": "Executive VP & CFO", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 339050, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Frederick E. Pierce II", "age": 63, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Barbara  Hibner Ph.D.", "age": 64, "title": "Chief Scientific Officer & Director", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nadeem Q. Mirza M.D., M.P.H.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter K. Marschel M.B.A., M.S.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.65, "open": 0.706, "dayLow": 0.6865, "dayHigh": 0.8976, "regularMarketPreviousClose": 0.65, "regularMarketOpen": 0.706, "regularMarketDayLow": 0.6865, "regularMarketDayHigh": 0.8976, "payoutRatio": 0.0, "beta": 0.324, "forwardPE": -0.09160305, "volume": 5962438, "regularMarketVolume": 5962438, "averageVolume": 1944406, "averageVolume10days": 976970, "averageDailyVolume10Day": 976970, "bid": 0.5089, "ask": 0.871, "bidSize": 2, "askSize": 2, "marketCap": 4924230, "fiftyTwoWeekLow": 0.515, "fiftyTwoWeekHigh": 108.0, "allTimeHigh": 1861504.6, "allTimeLow": 0.5148, "fiftyDayAverage": 1.23614, "twoHundredDayAverage": 7.057985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 114549, "profitMargins": 0.0, "floatShares": 5823312, "sharesOutstanding": 5862178, "sharesShort": 184642, "sharesShortPriorMonth": 467881, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0315, "heldPercentInsiders": 0.00637, "heldPercentInstitutions": 0.05219, "shortRatio": 0.31, "shortPercentOfFloat": 0.0315, "impliedSharesOutstanding": 5862179, "bookValue": 4.498, "priceToBook": 0.18674965, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -5004758, "trailingEps": -24.24, "forwardEps": -9.17, "lastSplitFactor": "1:15", "lastSplitDate": 1755475200, "enterpriseToEbitda": -0.021, "52WeekChange": -0.98510444, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 0.84, "recommendationKey": "none", "totalCash": 4809680, "totalCashPerShare": 0.82, "ebitda": -5563679, "totalDebt": 0, "quickRatio": 2.601, "currentRatio": 3.28, "returnOnAssets": -0.69908, "returnOnEquity": -1.39551, "freeCashflow": -2818466, "operatingCashflow": -4433218, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422541800000, "regularMarketChange": 0.19, "regularMarketDayRange": "0.6865 - 0.8976", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1944406, "fiftyTwoWeekLowChange": 0.325, "fiftyTwoWeekLowChangePercent": 0.63106793, "fiftyTwoWeekRange": "0.515 - 108.0", "fiftyTwoWeekHighChange": -107.16, "fiftyTwoWeekHighChangePercent": -0.99222225, "fiftyTwoWeekChangePercent": -98.510445, "dividendDate": 1563753600, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -24.24, "epsForward": -9.17, "fiftyDayAverageChange": -0.39614004, "fiftyDayAverageChangePercent": -0.32046536, "twoHundredDayAverageChange": -6.2179847, "twoHundredDayAverageChangePercent": -0.88098586, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "regularMarketChangePercent": 29.2308, "regularMarketPrice": 0.84, "shortName": "Salarius Pharmaceuticals, Inc.", "longName": "Salarius Pharmaceuticals, Inc.", "marketState": "CLOSED", "prevName": "Salarius Pharmaceuticals, Inc.", "nameChangeDate": "2026-01-09", "cryptoTradeable": false, "corporateActions": [{"header": "Ticker Change", "message": "SLRX is trading under new symbol DCOY effective Jan. 8, 2026", "meta": {"eventType": "TICKER_CHANGE", "dateEpochMs": 1767848400000, "newTicker": "DCOY"}}], "regularMarketTime": 1767819600, "exchange": "NCM", "messageBoardId": "finmb_330031056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Salarius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]